| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V0918 | A922500 | 959122-11-3 | A922500 (A-922500; A 922500) is a selective and orally bioactive inhibitor for human/mouseacyl CoA/diacylglycerol acyltransferase(DGAT-1) with anti-hyperlipidemic effects. |
|
V103775 | BMS-214662 mesylate | 474010-58-7 | BMS-214662 mesylate is a potent and selective farnesyltransferase inhibitor with IC50 of 1.35 nM. |
|
V0923 | FTI 277 HCl | 180977-34-8 | FTI 277 HCl (FTI-277; FTI277), the HCl salt of FTI 277, is a peptide mimetic of the COOH-terminal Cys-Val-Ile-Met of K-Ras4Bwhich is a novel, potent and selective farnesyltransferase (FTase) inhibitor with antiviral activity. |
|
V2627 | GGTI 298 TFA salt | 1217457-86-7 | GGTI 298 TFA (GGTI-298), the trifluoroacetic acid salt of GGTI 298, is a novel and potent geranylgeranyltransferase I (GGTase-I)inhibitor with ability to arrest human tumor cells in the G1 phase of the cell cycle and induce apoptosis. |
|
V0921 | LB42708 | 226929-39-1 | LB42708 (LB-42708; LB 42708) is a novel, potent, orally bioactive, and nonpeptidic farnesyltransferase (FTase) inhibitor with potential anti-inflammatory activity. |
|
V6524 | OSMI-1 | 1681056-61-0 | OSMI-1 (OSMI1; OSMI 1) is a novel, potent, cell permeable andquinolinone-6-sulfonamide-based inhibitor of O-GlcNAc transferase (OGT)with an IC50 value of 2.7 μM. |
|
V0922 | PF-04620110 | 1109276-89-2 | PF-04620110 (PF04620110; PF 04620110) is a novel, potent, orally bioactive, and selective diglyceride acyltransferase-1 (DGAT1) inhibitor with the potential to treat type 2 diabetes mellitus. |
|
V103920 | Squalene synthase-IN-2 | Squalene synthase-IN-2 (compound isomer A-(1S, 3R)-14i) is an orally active squalene synthase inhibitor with IC50 values of 3.4 and 99 nM for squalene synthase and cholesterol synthase, respectively. | |
|
V2456 | STM2457 | 2499663-01-1 | STM-2457 (STM2457; STM 2457) is a novel, first-in-class,orally bioactive and selective catalytic inhibitor of METTL3 (IC50 =16.9 nM) with potential antineoplastic activity. |
|
V8155 | Schisanhenol | 69363-14-0 | Schisandhenol is a natural compound that is reported to be an inhibitor (blocker/antagonist) of UGT2B7. |
|
V0919 | Tolcapone | 134308-13-7 | Tolcapone (Ro 40-7592; SOM-0226;Ro-407592; Tasmar), an approved anti-Parkinsons disease (PD) agent, is a reversible and orally bioavailable inhibitor of catechol-O-methyl transferase (COMT) with potential anti-PD effects. |
|
V0915 | Tipifarnib | 192185-72-1 | Tipifarnib (R-115777; LX-81; R115777; NSC-702818; D03720; Zarnestra), non-peptidomimetic quinolinone analog, is a potent and selective farnesyltransferase (FTase) inhibitor with potential antineoplastic activity. |
|
V0916 | Lonafarnib | 193275-84-2 | Lonafarnib (formerly SCH66336; SCH-66336; Sarasar; Zokinvy),a tricyclic derivative of carboxamide, is a novel, orally bioavailable and highly potent FPTase (farnesyl protein transferase) inhibitor with potential anticancer activity. |
|
V0917 | FK866 (APO866, Daporinad) | 658084-64-1 | Daporinad (APO866; FK-866; APO-866;K 22.175) is a novel and potent inhibitor of nicotinamide phosphoribosyltransferase (NMPRTase) with potential antitumor andantiangiogenic activity. |
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
